Synaffix and BigHat Biosciences collaborate to develop AI-designed ADC from BioPharma-Reporter.com
The Dutch biotech Synaffix and the Swiss company BigHat Biosciences announced yesterday that they have entered into a collaboration agreement to develop a new, next-in-class antibody-drug conjugate (ADC) program. The collaboration will combine Synaffix’s …